61768 Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Notices 

Contact Person: Cathleen L Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–443– 

4512, cooperc@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS). 

Dated: September 30, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25180 Filed 10–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Date: November 2–4, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Atlanta Hotel, 165 

Courtland Street, NE., Atlanta, GA 30303. 

Contact Person: Martha F Matocha, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, 

National Institutes of Health, 6701 

Democracy Blvd., 1 Democracy Plaza, Rm. 

1070, Bethesda, MD 20892, 301–435–0810, 

matocham@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards., National Institutes of 

Health, HHS). 

Dated: September 30, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25176 Filed 10–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, NIDDK KUHFellowship Review. 

Date: October 28, 2010. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call) 

Contact Person: Xiaodu Guo, M.D., PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 761, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–4719, 

guox@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Arteriovenous 

Fistula. 

Date: November 5, 2010. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. 

Contact Person: Michael W. Edwards, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 750, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8886, 

edwardsm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS). 

Dated: September 30, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25173 Filed 10–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Commission on 

Childhood Vaccines (ACCV). 

Date and Time: October 28, 2010, 9 

a.m. to 5 p.m. EDT. 

Place: Parklawn Building (and via 

audio conference call), Conference 

Rooms G & H, 5600 Fishers Lane, 

Rockville, MD 20857. 

The ACCV will meet on Thursday, 

October 28 from 9 a.m. to 5 p.m. (EDT). 

The public can join the meeting via 

audio conference call by dialing 1–877– 

784–3230 on October 28 and providing 

the following information: 

Leader’s Name: Dr. Geoffrey Evans. 

Password: ACCV. 

Agenda: The agenda items for the 

October meeting will include, but are 

not limited to: Updates from the 

Division of Vaccine Injury 

Compensation (DVIC), Department of 

Justice (DOJ), National Vaccine Program 

Office, Immunization Safety Office 

(Centers for Disease Control and 

Prevention), National Institute of 

Allergy and Infectious Diseases 

(National Institutes of Health), Center 

for Biologics, Evaluation and Research 

(Food and Drug Administration), a 

discussion on the VICP outreach efforts, 

and a review of Vaccine Information 

Statements (VISs). A draft agenda and 

additional meeting materials will be 

posted on the ACCV Web site (http:// 

www.hrsa.gov/vaccinecompensation/ 

accv.htm) prior to the meeting. Agenda 

items are subject to change as priorities 

dictate. 

Public Comment: Persons interested 

in providing an oral presentation should 

submit a written request, along with a 

copy of their presentation to: Annie 

Herzog, DVIC, Healthcare Systems 

Bureau (HSB), Health Resources and 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Notices 61769 

Services Administration (HRSA), Room 

11C–26, 5600 Fishers Lane, Rockville, 

Maryland 20857 or e-mail: 

aherzog@hrsa.gov. Requests should 

contain the name, address, telephone 

number, e-mail address, and any 

business or professional affiliation of 

the person desiring to make an oral 

presentation. Groups having similar 

interests are requested to combine their 

comments and present them through a 

single representative. The allocation of 

time may be adjusted to accommodate 

the level of expressed interest. DVIC 

will notify each presenter by e-mail, 

mail or telephone of their assigned 

presentation time. Persons who do not 

file an advance request for a 

presentation, but desire to make an oral 

statement, may announce it at the time 

of the comment period. Public 

participation and ability to comment 

will be limited to space and time as it 

permits. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requiring information regarding 

the ACCV should contact Annie Herzog, 

DVIC, HSB, HRSA, Room 11C–26, 5600 

Fishers Lane, Rockville, MD 20857; 

telephone (301) 443–6593 or e-mail: 

aherzog@hrsa.gov. 

Dated: September 27, 2010. 

Sahira Rafiullah, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2010–25115 Filed 10–5–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

Date: December 13, 2010. 

Time: 12:30 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Dem II, 

6707 Democracy Boulevard, Bethesda, MD 

20892. (Telephone Conference Call) 

Contact Person: Manana Sukhareva, PhD, 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Boulevard, Suite 959, Bethesda, 

MD 20892, 301–451–3397, 

sukharem@mail.nih.gov. 

Dated: September 30, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25172 Filed 10–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

October 29, 2010, 2 p.m. to October 29, 

2010, 4 p.m., National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892 which was published in the 

Federal Register on September 23, 2010, 

75 FR 57965–57967. 

The meeting times have been changed 

to 8:30 a.m. to 10:30 a.m. on October 29, 

2010. The meeting date and location 

remain the same. The meeting is closed 

to the public. 

Dated: September 29, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25171 Filed 10–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

Agency Information Collection 

Activities: Form I–912, New 

Information Collection; Comment 

Request 

ACTION: 30-Day Notice of Information 

Collection Under Review: Form I–912, 

Request for Fee Waiver; OMB Control 

No. 1615–New. 

The Department of Homeland 

Security, U.S. Citizenship and 

Immigration Services (USCIS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The information collection was 

previously published in the Federal 

Register on July 14, 2010, at 75 FR 

40846, allowing for a 60-day public 

comment period. USCIS received 30 

comments from members of the public 

for this information collection. These 

comments have been addressed in item 

8 of the supporting statement which 

will be posted to http:// 

www.regulations.gov. 

The purpose of this notice is to allow 

an additional 30 days for public 

comments. Comments are encouraged 

and will be accepted until November 5, 

2010. This process is conducted in 

accordance with 5 CFR 1320.10. 

Written comments and/or suggestions 

regarding the item(s) contained in this 

notice, especially regarding the 

estimated public burden and associated 

response time, should be directed to the 

Department of Homeland Security 

(DHS), and to the Office of Management 

and Budget (OMB) USCIS Desk Officer. 

Comments may be submitted to: USCIS, 

Chief, Regulatory Products Division, 20 

Massachusetts Avenue, Washington, DC 

20529–2020. Comments may also be 

submitted to DHS via facsimile to 202– 

272–8352 or via e-mail at 

rfs.regs@dhs.gov, and to the OMB USCIS 

Desk Officer via facsimile at 202–395– 

5806 or via e-mail at 

oira_submission@omb.eop.gov. When 

submitting comments by e-mail please 

make sure to add OMB Control Number 

1615–New in the subject box. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 

four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

mstockstill on DSKH9S0YB1PROD with NOTICES